-
公开(公告)号:US11643551B2
公开(公告)日:2023-05-09
申请号:US16642053
申请日:2018-08-28
Applicant: DSM IP Assets B.V.
Inventor: Jennifer Al-Rashid , Jacob Riffey , Chad Sugiyama , John Zupancich
IPC: C08L75/08 , A61B5/145 , A61B5/1473 , B01D67/00 , B01D69/02 , B01D71/54 , B01D71/58 , C08G18/24 , C08G18/28 , C08G18/48 , C08G18/66 , C08G18/73 , C08G18/75 , C08J5/18 , C12Q1/00
CPC classification number: C08L75/08 , A61B5/14532 , A61B5/14735 , B01D67/0011 , B01D67/0095 , B01D69/02 , B01D71/54 , B01D71/58 , C08G18/244 , C08G18/283 , C08G18/2825 , C08G18/4808 , C08G18/4833 , C08G18/4854 , C08G18/6674 , C08G18/73 , C08G18/755 , C08G18/758 , C08J5/18 , C12Q1/00 , A61B5/14546 , B01D2323/12 , B01D2325/34 , B01D2325/36 , C08J2375/08 , C08J2475/04 , C08L2203/16 , C08L2205/025
Abstract: Disclosed are compositions that may be useful for forming synthetic membranes, methods of forming membranes therefrom, and membranes. In an embodiment, a membrane comprises a free hydrophilic polymer comprising a polyoxazoline, and a polyurethane, the polyurethane comprising a backbone comprising the reaction product of a diisocyanate, a polymeric aliphatic 5 diol, and optionally a chain extender.
-
公开(公告)号:US12252614B2
公开(公告)日:2025-03-18
申请号:US18127892
申请日:2023-03-29
Applicant: DSM IP Assets B.V.
Inventor: Jennifer Al-Rashid , Jacob Riffey , Chad Sugiyama , John Zupancich
IPC: C08L75/08 , A61B5/145 , A61B5/1473 , B01D67/00 , B01D69/02 , B01D71/54 , B01D71/58 , C08G18/24 , C08G18/28 , C08G18/48 , C08G18/66 , C08G18/73 , C08G18/75 , C08J5/18 , C12Q1/00
Abstract: Disclosed are compositions that may be useful for forming synthetic membranes, methods of forming membranes therefrom, and membranes. In an embodiment, a membrane comprises a free hydrophilic polymer comprising a polyoxazoline, and a polyurethane, the polyurethane comprising a backbone comprising the reaction product of a diisocyanate, a polymeric aliphatic 5 diol, and optionally a chain extender.
-
公开(公告)号:US12214041B2
公开(公告)日:2025-02-04
申请号:US17275729
申请日:2019-09-16
Applicant: DSM IP Assets B.V.
Inventor: Jennifer Al-Rashid , Jacob Riffey , John Andrew Zupancich
IPC: A61K47/34 , A61K9/00 , A61K47/32 , C08G18/08 , C08G18/12 , C08G18/32 , C08G18/40 , C08G18/44 , C08G18/48 , C08G18/73 , C08G18/75
Abstract: In an embodiment, a polyurethane comprises the residues of i. an aliphatic diisocyanate, ii. an aliphatic diol comprising a poly(ethylene oxide) moiety, iii. an aliphatic diol comprising a polycarbonate moiety, and iv. a chain extender, wherein the polyurethane has a melting temperature of 140° C. or less and has a weight average molecular weight of from 100,000 to 500,000 g/mol. In an embodiment, the polyurethane is substantially devoid of catalyst. In an embodiment, the polyurethane is formed by reactive extrusion. In an embodiment, a medical device comprises the polyurethane and a bioactive agent. The medical devices, methods, and polyurethanes may exhibit benefits in end-product biostability, drug release profile, health and safety, and processing speed or reproducibility.
-
-